Deal

Follow-up investment in Probio

Norinnova Invest has made a follow-up investment of NOK 9.2 million in ProBio Nutraceuticals, making the fund's total investment in the company NOK 21.8 million.

Tromsø based ProBio was founded in 2000 and has two main activities: Nutrients and Pharma & Supplements. The company is a leading player in the North-European market for production of high-quality Omega 3 products.

In addition to Norinnova Invest, Norinnova owns 9.7 percent of the company.

Read more

 


FundNorInnova Invest
Portfolio CompanyProBio Nutraceuticals
Date of Transaction2010-08-11
TransactionFinance round
Seller
Buyer
Size of TransactionNOK 9.2m
Ind. FocusOther
GeographyNorway
StageSeed
 

More deals

(2011-07-13)